Overview

Study to Proof the Clinical and Bacteriological Non-inferiority of Ampicillin/Amoxicillin Versus Moxifloxacin in Hospitalized Patients With Non-severe Community-acquired Pneumonia

Status:
Terminated

Trial end date:
2011-01-01

Target enrollment:

Participant gender:

Summary

The purpose of this study is to prove the clinical and bacteriological non-inferiority of ampicillin/amoxicillin versus moxifloxacin in hospitalized patients with non-severe community-acquired pneumonia.

Phase:

Phase 4

Details

Lead Sponsor:

University of Ulm

Collaborator:

CAPNETZ Stiftung

Treatments:

Amoxicillin
Ampicillin
Fluoroquinolones
Moxifloxacin
Norgestimate, ethinyl estradiol drug combination